Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.36% |
| 2 | Technology | 9.28% |
| 3 | Financials | 7.68% |
| 4 | Healthcare | 6.5% |
| 5 | Industrials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Gray Television
GTN
$497M
| $2.88M | ﹤0.01% |
498,187
+342,564
| +220% | +$1.86M |
|
|
OACC
3602
Oaktree Acquisition Corp III Life Sciences
OACC
$264M
| $2.88M | ﹤0.01% |
273,914
| – | – |
|
3603
Choice Hotels
CHH
$4.9B
| $2.88M | ﹤0.01% |
26,898
-543,539
| -95% | -$66.4M |
|
3604
PUT
Ecolab
ECL
$80.4B
| $2.88M | ﹤0.01% |
10,500
-17,100
| -62% | -$4.64M |
|
3605
Acadia Realty Trust
AKR
$2.85B
| $2.87M | ﹤0.01% |
142,656
-536,558
| -79% | -$10.3M |
|
3606
Mercer International
MERC
$25.9M
| $2.87M | ﹤0.01% |
994,974
+137,906
| +16% | +$455K |
|
3607
Wave Life Sciences
WVE
$993M
| $2.86M | ﹤0.01% |
390,749
-301,666
| -44% | -$2.44M |
|
3608
CALL
Toll Brothers
TOL
$13.5B
| $2.86M | ﹤0.01% |
20,700
+16,100
| +350% | +$2.1M |
|
|
GEMI
3609
Gemini Space Station
GEMI
$558M
| $2.85M | ﹤0.01% |
+118,948
| New | +$3.07M |
|
3610
Angi Inc
ANGI
$204M
| $2.85M | ﹤0.01% |
175,271
+96,167
| +122% | +$1.65M |
|
3611
PUT
Five Below
FIVE
$13.4B
| $2.85M | ﹤0.01% |
18,400
-36,800
| -67% | -$5.21M |
|
3612
Capital Southwest
CSWC
$1.62B
| $2.84M | ﹤0.01% |
130,052
-396,682
| -75% | -$9.03M |
|
|
PACH
3613
Pioneer Acquisition I Corp
PACH
$293M
| $2.84M | ﹤0.01% |
+285,001
| New | +$2.84M |
|
3614
PACS Group
PACS
$6.77B
| $2.84M | ﹤0.01% |
206,655
+31,736
| +18% | +$372K |
|
3615
Arcutis Biotherapeutics
ARQT
$2.99B
| $2.83M | ﹤0.01% |
150,099
-760,742
| -84% | -$12M |
|
3616
CALL
Mobileye
MBLY
$7.29B
| $2.82M | ﹤0.01% |
200,000
+166,500
| +497% | +$2.48M |
|
|
3617
CALL
Norfolk Southern
NSC
$78.3B
| $2.82M | ﹤0.01% |
9,400
-15,900
| -63% | -$4.42M |
|
3618
AB InBev
BUD
$158B
| $2.82M | ﹤0.01% |
47,327
-54,852
| -54% | -$3.45M |
|
|
AMWD
3619
DELISTED
American Woodmark
AMWD
| $2.82M | ﹤0.01% |
42,178
-56,698
| -57% | -$3.48M |
|
3620
ADC Therapeutics
ADCT
$146M
| $2.81M | ﹤0.01% |
701,619
+317,945
| +83% | +$1M |
|
3621
GSK
GSK
$102B
| $2.8M | ﹤0.01% |
64,990
-13,437
| -17% | -$525K |
|
|
JMIA
3622
Jumia Technologies
JMIA
$865M
| $2.8M | ﹤0.01% |
241,549
+157,227
| +186% | +$1.15M |
|
3623
CALL
CACI
CACI
$13.9B
| $2.79M | ﹤0.01% |
5,600
| – | – |
|
3624
Genmab
GMAB
$20.4B
| $2.79M | ﹤0.01% |
90,913
-295,383
| -76% | -$7.2M |
|
|
ABTC
3625
American Bitcoin Corp
ABTC
$560M
| $2.79M | ﹤0.01% |
+27,566
| New | +$2.76M |
|
Similar funds
Israel Englander's Q3 2025 Portfolio in Review
As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
- Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Israel Englander opened 800 new positions and closed 633 in Q3 2025.
- Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.